CDC Releases Additional Doses of Nirsevimab-Alip for RSV Immunization in Infants

More than 77,000 additional doses of nirsevimab-alip will be distributed for respiratory syndactyl virus (RSV) immunization in infants.

Related Keywords

United States ,Alaska ,American ,Niravd Shah ,Patrizia Cavazzoni ,American College Of Obstetricians ,American College ,American Indian ,Alaska Native ,Drug Evaluation ,Rsv Vaccines ,Fda Approval ,Nirsevimab ,Beyfortus ,Rsv Vaccines For Infants ,